Medical data has traditionally been difficult to obtain. Yet access for health care providers could help to reduce some of the $1.6 trillion spent annually on healthcare costs for chronic conditions in the U.S. alone.
OM1 is a medical data service company offering real-time patient data for health professionals to review and utilize. This aggregated data assists with the early identification of illnesses and can be used as evidence in regulatory approvals. OM1 has launched a series of registries where medical professionals can share data and insights for specific conditions such as Multiple Sclerosis and Osteoarthritis.
Other companies attracting interest in this space include HealthVerity and Aetion, which supply databases used by pharmaceutical companies for drug research and development. OM1 sits apart from these providers in a middle-tier away from the large data centers but larger than providers focused on data from smaller research groups.
The company is focused on developing its platform, with a focus on adding datasets to help tackle Parkinson's disease and building out an AI-based product to provice personalised information about diagnosis, treatments and risks from a dataset composed of the records of over 300 million patients.
Freddie
Company Specialist at Welcome to the Jungle